Cohort Profile: The Metabolic syndrome and Cancer project (Me-Can)
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The metabolic syndrome includes presence of several metabolic risk factors, such as obesity, hypertension, insulin resistance/hyperglycaemia and dyslipidaemia.1 These factors have, separately and jointly, been associated with an increased risk of cardiovascular diseases.2–4 To date, little is known about the metabolic syndrome and cancer risk.5 Recent prospective studies have either focused on the association between the metabolic syndrome and risk of specific cancers, mainly colorectal and prostate cancer, or between a single factor in the metabolic syndrome and cancer risk.5 It remains to be elucidated if factors within the metabolic syndrome act in synergy on the risk of cancer. In 2006, we initiated the Metabolic syndrome and Cancer project (Me-Can) in order to create a large pooled cohort to investigate factors of the metabolic syndrome on the association with cancer risk. Existing cohorts in Norway, Austria and Sweden were included in the project. The cohorts were: in Norway, the Oslo study I (Oslo), the Norwegian Counties Study (NCS), the Cohort of Norway (CONOR) and the Age 40 programme (40-years); in Austria, the Vorarlberg Health Monitoring and Prevention Programme (VHM&PP); and in Sweden, the Västerbotten Intervention Project (VIP) and the Malmö Preventive Project (MPP) (Figure 1). The co-ordinating centre is at the Department of Surgical and Perioperative sciences, Umeå University, Sweden, and the Me-Can database is stored at the Oncological Centre, Umeå University, Sweden. The Me-Can project was approved by ethical committees in the respective countries. Map with location of subcohorts included in Me-Can. The 40-year cohort includes all counties in Norway (all grey- and black-marked areas in Norway), NCS includes areas and , the CONOR includes areas and , and further cohorts (marked in black) are; Oslo I, VHM&PP, VIP and the MPP The aim of Me-Can studies is to investigate the relation between factors in the metabolic syndrome and cancer risk. Key exposure factors are body mass index (BMI), blood pressure, blood glucose and serum levels of total cholesterol and triglycerides. The specific purpose of the Me-Can project is to study the effect of these factors, separately and combined, on the association with risk of cancer overall and of specific cancer sites among men and women, and to use both incident and fatal cancer as endpoints. All subjects in the Me-Can cohorts underwent one or more health examination(s) and, except for in the VHM&PP, participants were asked to fill in a questionnaire in connection with the examination. The questionnaires covered lifestyle factors and various topics of specific interest for each programme. In the VHM&PP, the examining physician asked about lifestyle issues and answers were recorded; however, tobacco use is the only lifestyle factor with sufficient validity and coverage among participants for use in studies. The Norwegian cohorts were all initiated by the Norwegian Institute of Public Health, or the former National Health Screening Service in Norway (now part of the Norwegian Institute of Public Health), and thus, the design of these surveys were similar. The Oslo study I is the first of two rounds of surveys conducted among men in Oslo, the capital city of Norway.6,7 All men aged 40–49 years and a random selection (7%) of men aged 20–39 years were invited to attend a health survey programme during the period 1972–73. The purpose was to study the prevention and epidemiology of cardiovascular diseases. The attendance rate in the Oslo study I was 60%; nearly 18 000 individuals participated in the study. Data from the second round of the Oslo study, conducted in 2000, are part of the CONOR study. Screening for cardiovascular disease prevention was performed in the Norwegian counties, Finnmark, Sogn og Fjordane and Oppland in three time periods: 1974–78, 1977–83 and 1985–88.8,9 All residents in these counties aged 35–49 years and a random sample of 20–34-year-old subjects were invited to the screening in 1974–78. The sample invited to the second and third screening was a combination of previous participants and new cohorts. The attendance rate in the screening periods and the counties was between 78 and 90% and altogether, approximately 93 000 individuals participated in the NCS. The CONOR was established by the Norwegian Ministry of Health and is a research collaboration between the Norwegian Institute of Public Health and the Universities of Bergen, Oslo, Tromsø and Trondheim.10 The purpose of the establishment of CONOR was to set up a cohort that included core survey data and stored blood samples for future research on aetiological factors for a variety of diseases. A standardized protocol was used for all common measurements in surveys included in CONOR. Several surveys from different regions in Norway, and within different age groups, provide data for the CONOR; the first data are from the year 1994. The attendance rate in CONOR surveys was on average 56%
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Cited by
Visceral obesity, metabolic syndrome, insulin resistance and cancer
Doyle, S. L., Donohoe, C. L., Lysaght, J., & Reynolds, J. V. (2012) · Proceedings of the Nutrition Society · doi:10.1017/s002966511100320x · Cited by 309
Stocks, T., Van Hemelrijck, M., Manjer, J., Bjørge, T., Ulmer, H., Hallmans, G., Lindkvist, B., Selmer, R., Nagel, G., Tretli, S., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.189258 · Cited by 286
Self-citationVisceral adiposity, insulin resistance and cancer risk
Donohoe, C. L., Doyle, S. L., & Reynolds, J. V. (2011) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-3-12 · Cited by 247
Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults
Borena, W., Strohmaier, S., Lukanova, A., Bjørge, T., Lindkvist, B., Hallmans, G., Edlinger, M., Stocks, T., Nagel, G., Manjer, J., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.26338 · Cited by 177
Self-citationMetabolic risk score and cancer risk: pooled analysis of seven cohorts
Stocks, T., Bjørge, T., Ulmer, H., Manjer, J., Häggström, C., Nagel, G., Engeland, A., Johansen, D., Hallmans, G., Selmer, R., et al. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv001 · Cited by 146
Self-citation
Metadata
- Authors
- Stocks, T., Borena, W., Strohmaier, S., Bjorge, T., Manjer, J., Engeland, A., Johansen, D., Selmer, R., Hallmans, G., Rapp, K., Concin, H., Jonsson, H., Ulmer, H., & Stattin, P.
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-04-20
- Volume
- 39
- Issue
- 3
- Pages
- 660-667
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- OpenAlex
- W2159615668
- Cited by
- 92
- References
- 1
- FWCI
- 4.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.